Drug interaction between phenytoin and valproic acid in a child with refractory epilepsy: a case report

Indira Valadê Carvalho1, Renata Cavalcanti Carnevale, Marília Berlofa Visacri

  • 1Department of Clinical Pathology, Faculty of Medical Sciences, University of Campinas, Campinas, Brazil.

Insights

Pediatric phenytoin toxicity occurred in a 12-year-old due to a drug interaction with valproic acid. This interaction increased free phenytoin levels, causing toxicity despite appropriate dosing.

Area of Science:

  • Pediatric Neurology
  • Clinical Pharmacology
  • Pharmacogenetics

Background:

  • Limited published data exists on phenytoin toxicity in pediatric patients.
  • Phenytoin is a commonly used antiepileptic drug, necessitating understanding of its interactions.

Observation:

  • A 12-year-old with refractory epilepsy developed phenytoin toxicity.
  • The patient was receiving concurrent treatment with phenytoin, valproic acid, and lamotrigine.
  • Serum phenytoin levels were supratherapeutic (21.92 µg/mL) despite appropriate capsule concentration and dosage.

Findings:

  • Phenytoin toxicity was observed despite appropriate drug formulation and dosage.
  • Valproic acid is implicated in increasing free phenytoin serum concentrations.
  • The mechanism involves displacement of phenytoin from plasma proteins and inhibition of its metabolism.

Implications:

  • Highlights a critical drug interaction between valproic acid and phenytoin in pediatric epilepsy management.
  • Underscores the importance of therapeutic drug monitoring for phenytoin, especially when co-administered with valproic acid.
  • Suggests potential for dose adjustments or alternative antiepileptic strategies in such cases.
Abstract

Related Concept Videos

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.7K
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
695
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
2.4K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
1.0K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.3K